Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. Mai 2024 07:00 ET | Quelle: Macerich Company

Macerich Launches Path-Forward Plan

Macerich Launches Path-Forward Plan, Three-Part Strategy to Simplify the Business, Improve Operational Performance, and Reduce Leverage
16. Mai 2024 10:08 ET | Quelle: Macerich Company

CORRECTION - Macerich Announces Initial Progress in its Path Forward Strategic Plan

SANTA MONICA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Macerich (NYSE: MAC), please note in the third paragraph, the amount the...
16. Mai 2024 09:26 ET | Quelle: Macerich Company

UPDATE - Macerich Announces Initial Progress in its Path Forward Strategic Plan

SANTA MONICA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: MAC), one of the nation’s leading owners, operators and developers of major retail properties in top markets, today announced...
16. Mai 2024 06:00 ET | Quelle: Macerich Company

Macerich Announces Initial Progress in its Path Forward Strategic Plan

SANTA MONICA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: MAC), one of the nation’s leading owners, operators and developers of major retail properties in top markets, today announced...
30. Mai 2019 16:02 ET | Quelle: Ascendis Pharma A/S

Ascendis Pharma A/S Reports First Quarter 2019 Financial Results

– Continued execution of global endocrinology rare disease programs, following validation of TransCon™ platform in phase 3 heiGHt Trial – – R&D Day on June 26 to feature endocrinology and...